| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -0.10 | NA | NA |
| EPS, GAAP | 0.10 | -0.03 | NA |
| Consensus Estimate | -0.12 | NA | NA |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | NA | -0.36 | NA |
| EPS, GAAP | 0.09 | -0.44 | NA |
| Consensus Estimate | NA | NA | NA |
| PLX | Industry Average | |
| P/E (TTM) | 72.33 | 86.30 |
| P/E (Forward) | NA | -4.30 |
| PEG Ratio | NA | -0.21 |
| Price/Sales | 61.42 | 4.64 |
| Beta | 1.56 | 1.55 |
| 12/8/2011 | Are these stocks making short work of short-sellers? (The Motley Fool) |
| 12/7/2011 | Another delay for Protalix BioTherapeutics makes you think. (The Motley Fool) |
| 12/7/2011 | Are these three stocks set up for a large move? (The Motley Fool) |
| 12/6/2011 | Is this meaningful or just another movement? (The Motley Fool) |
| 12/6/2011 | Stocks to Watch: Leap, Darden and More (WSJ.com) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)
